En
The "EFMC-WuXi AppTec Award for Excellence in Chemical Biology" will recognise outstanding research in the field of chemical biology as defined by EFMC in The Chemical Biology-Medicinal Chemistry Continuum: EFMC’s Vision1, ChemBioChem 2021, 22, 2823-2825 link (free access). The Award is given biennially and consists of a diploma, € 7.500 and an invitation to present a lecture at an EFMC-ISCB symposium.
The Award shall be open to any scientist whose age does not exceed 50 years on January 1st of the year during which the Award is to be presented, and whose accomplishment has not yet been honoured by other EFMC awards. In accordance with the EFMC core values of equal opportunities and inclusiveness; Maternity leaves, as well as leaves taken for health or private reasons are considered upon making the final selection.
Nominations should consist of:
Self-nominations are also accepted.
The Award will be presented at the 2nd EFMC International Symposium on Chemoical Biology (EFMC-ISCB 2025) to be held in Basel, Switerland on January 29-31, 2025.
Deadline for submission: June 30, 2024 | Awardee will be announced in the course of September 2024!
The 2023 EFMC-WuXi AppTec Award for Excellence in Chemical Biology has been awarded to:
Prof. Gonçalo Bernardes (University of Cambridge, UK & IMM Lisboa, Portugal)
For his ground-breaking contributions to the field of chemical biology and cancer biology with meCLICK-Seq, a substrate-hijacking and RNA degradation strategy for the study of RNA methylation, and small molecules that are efficacious in vivo using platinum activators. His innovative research pursues key questions in chemistry and molecular medicine by using innovative strategies that bridge disciplines and inspire the programmes of other researchers.
About Gonçalo Bernardes:
Gonçalo Bernardes is a Professor of Chemical Biology at the Department of Chemistry, University of Cambridge, UK and Fellow of Trinity Hall College, Cambridge, UK.
After completing his D.Phil. in 2008 at the University of Oxford, U.K., he undertook postdoctoral work at the Max-Planck Institute of Colloids and Interfaces, Germany, and the ETH Zürich, Switzerland, and worked as a Group Leader at Alfama Lda in Portugal. He started his independent research career in 2013 at the University of Cambridge as a Royal Society University Research Fellow. In 2018 he was appointed University Lecturer (Tenured), and he has been promoted to Reader (Associate Professor) in 2019 and to Full Professor in 2022.
1For a more complete definition of medicinal chemistry and chemical biology as understood by EFMC, please see Duca M, Gillingham D, Adam Olsen C, Sbardella G, van der Stelt M, Vasquez O, Vauzeilles B, Auberson YP. The Chemical Biology-Medicinal Chemistry Continuum: EFMC’s Vision. ChemBioChem 2021, 22, 2823– 2825. link
